Midecamycin
{{Short description|Chemical compound}}
{{Drugbox
| Watchedfields = changed
| verifiedrevid = 444413988
| IUPAC_name = (2S,3S,4R,6S)-6-
| image = Midecamycin.png
| tradename =
| Drugs.com = {{drugs.com|international|midecamycin}}
| pregnancy_AU =
| pregnancy_US =
| pregnancy_category =
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US =
| legal_status =
| routes_of_administration =
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 35457-80-8
| ATC_prefix = J01
| ATC_suffix = FA03
| PubChem = 5382853
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4445365
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = N34Z0Y5UH7
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01339
| C=41 | H=67 | N=1 | O=15
| smiles = O=CC[C@H]3C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@H](OC(=O)C[C@@H](OC(=O)CC)[C@H](OC)[C@H]3O[C@@H]2O[C@@H]([C@@H](O[C@@H]1O[C@H]([C@H](OC(=O)CC)[C@](O)(C1)C)C)[C@H](N(C)C)[C@H]2O)C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C41H67NO15/c1-11-30(45)54-29-21-32(47)51-24(4)16-14-13-15-17-28(44)23(3)20-27(18-19-43)37(38(29)50-10)57-40-35(48)34(42(8)9)36(25(5)53-40)56-33-22-41(7,49)39(26(6)52-33)55-31(46)12-2/h13-15,17,19,23-29,33-40,44,48-49H,11-12,16,18,20-22H2,1-10H3/b14-13+,17-15+/t23-,24-,25-,26+,27+,28+,29-,33+,34-,35-,36-,37+,38+,39+,40+,41-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = DMUAPQTXSSNEDD-QALJCMCCSA-N
| melting_point = 155
| melting_high = 156
| solubility = Soluble in acidic/low pH water; Very soluble in methanol, chloroform, ethyl acetate, benzene, ethyl ether; Almost completely in ethanol(>95.5)
}}
Midecamycin is a macrolide antibiotic{{cite journal | vauthors = Salhi A, Vindel JA, Brunaud M, Berceaux G, Marin A, Wuatelet C | title = Properties of midecamycin, a new macrolide antibiotic | journal = Giornale Italiano di Chemioterapia | volume = 24 | issue = 1–2 | pages = 67–76 | date = 1977 | pmid = 308022 }} that is synthesized from Streptomyces mycarofaciens.{{cite journal | vauthors = Wang YG, Hutchinson CR | title = Cloning of midecamycin biosynthetic genes from Streptomyces mycarofaciens 1748 | journal = Chinese Journal of Biotechnology | volume = 5 | issue = 4 | pages = 191–201 | date = 1989 | pmid = 2491329 }}
Physical Properties
Its melting point may vary depending on the compound type and the source consulted. For example, the Merck Index gives a melting point of 155-156 Celsius for the A1 type while the Japanese Pharmacopoeia reports 153-158 Celsius. The Merck Index also gives a melting point of 122-125 Celsius for the A3 type.{{cn|date=January 2023}}
References
{{Reflist}}
{{Antibiotic-stub}}
{{Macrolides, lincosamides and streptogramins}}
Category:Macrolide antibiotics